Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.02 CHF | -0.33% | +2.57% | +0.52% |
Jun. 07 | Nestlé Unit to Buy Vowst Assets from Seres Therapeutics | MT |
Jun. 06 | Nestlé: acquisition of a drug derived from microbiota | CF |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's enterprise value to sales, at 3.26 times its current sales, is high.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.52% | 287B | A- | ||
-6.38% | 90.96B | C+ | ||
-7.00% | 41.76B | C+ | ||
+2.28% | 41.74B | B- | ||
+5.16% | 39.65B | B- | ||
+3.56% | 38.08B | B- | ||
-15.16% | 30.29B | B- | ||
-5.86% | 28.91B | A | ||
+8.15% | 24.27B | A- | ||
-11.20% | 22.18B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NESN Stock
- Ratings Nestlé S.A.